Characterization of a high copy number amplification at 6q24 in pancreatic cancer identifies c-myb as a candidate oncogene

Cancer Research

Volumn 57, Issue 15, 1997, Pages 3135-3139

  Wallrapp, Christine ^a   Müller Pillasch, Friederike ^a   Solinas Toldo, Sabina ^b   Lichter, Peter ^b   Friess, Helmut ^c   Büchler, Markus ^c   Fink, Thomas ^d   Adler, Guido ^a   Gress, Thomas M ^a  

^a UNIVERSITY OF ULM   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF BERN   (Switzerland)

^d Medizinisches Versorgungszentrum Labor Prof Seelig   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EUKARYOTIC RELEASE FACTOR; ONCOPROTEIN; ONCOPROTEIN C MYB; TRANSLATION TERMINATION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CHROMOSOME 6Q; EXON; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; ONCOGENE C MYB; PANCREAS CANCER; PRIORITY JOURNAL; SOUTHERN BLOTTING; YEAST ARTIFICIAL CHROMOSOME;

ADENOCARCINOMA; BLOTTING, SOUTHERN; CHROMOSOMES, ARTIFICIAL, YEAST; CHROMOSOMES, HUMAN, PAIR 6; GENE AMPLIFICATION; GENE EXPRESSION; HUMANS; MOLECULAR SEQUENCE DATA; PANCREATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MYB; TRANS-ACTIVATORS;

EID: 0030795405     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Schwab, M. Where pathology meets molecular biology: N-myc amplification in human neuroblastoma as a paradigm for the clinical use of an oncogene alteration. Verh. Dtsch. Ges. Pathol., 78: 26-33, 1994.
2. Murr, M. M., Sarr, M. G., Oishi, A. J., and van Heerden, J. A. Pancreatic cancer. CA Cancer J. Clin., 44: 304-318, 1994.
3. Myers. M. H., and Ries, L. A. Cancer patient survival rates: SEER program results for 10 years of follow-up. CA Cancer J. Clin., 39: 21-32, 1989.
4. Solinas-Toldo, S., Wallrapp, C., Müller-Pillasch, F., Bentz, M., Gress, T., and Lichter, P. Mapping of chromosomal imbalances in pancreatic carcinoma by comparative genomic hybridization. Cancer Res., 56: 3803-3807, 1996.
5. Hermanek, P., and Sobin, L. H. (eds.). TNM Classification of Malignant Tumors, ed. 4, revision 2, pp. 71-73. New York: Springer-Verlag New York, Inc., 1992.
6. Roux, K. H., and Dhanarajan, P. A strategy for single-site PCR amplification of dsDNA: priming digested cloned or genomic DNA from an anchor-modified restriction site and a short internal sequence (Published erratum in Biotechniques, 8 (Suppl. 3): 265, 1990). Biotechniques, 8: 48-57, 1990.
7. Church, D. M., Stotler, C. J., Rutter, J. L., Murrell, J. R., Trofalter, J. A., and Buckler, A. J. Isolation of genes from complex sources of mammalian genomic DNA using exon amplification. Nat. Genet., 6: 98-105, 1994.
8. Gress, T. M., Müller-Pillasch, F., Geng, M., Zimmerhackl, F., Zehetner, G., Friess, H., Büchler, M., Adler, G., and Lehrach, H. A pancreatic cancer-specific expression profile. Oncogene, 13: 1819-1830, 1996.
9. Lichter, P., Tang, C. C., Call, K., Hermanson, G., Evans, G. A., Housman, D., and Ward, D. C. High-resolution mapping of human chromosome 11 by in situ hybridization with cosmid clones. Science (Washington DC), 247: 64-69, 1990.
10. Dozier, C., Walbaum, S., Leprince, D., and Stehelin, D. E??oRI RFLP linked to the human myb gene. Nucleic Acids Res., 14: 1928, 1986.
11. Graf, T. Myb: a transcriptional activator linking proliferation and differentiation in hematopoietic cells (Published erratum in Curr. Opin. Genet. Dev., 2 (Suppl. 3): 504, 1992). Curr. Opin. Genet. Dev., 2: 249-255, 1992.
12. Pellicci, P. G., Lanfrancone, L., Brathwaite, M. D., Wolman, S. R., and Dalla-Favera, R. Amplification of c-myb oncogene in a case of human acute myelogenous leukemia. Science (Washington DC), 224: 1117-1121, 1984.
13. Zhou, D. J., Ahuja, H., and Cline, M. J. Proto-oncogene abnormalities in human breast cancer: c-ERBB-2 amplification does not correlate with recurrence of disease. Oncogene, 4: 105-108, 1989.
14. Alitalo, K., Winqvist, R., Lin, C. C., De la Chapelle, A., Schwab, M., and Bishop, J. M. Aberrant expression of amplified c-myb oncosene in two cell lines from a colon carcinoma. Proc. Natl. Acad. Sci. USA, 81: 4534-4538, 1984.
15. Kiefer, P. E., Bepler, G., Kubasch, M., and Havemann, K. Amplification and expression of protooncosenes in human small cell lung cancer cell lines. Cancer Res., 47: 6236-6242, 1987.
16. Greco, C., Gandolfo, G. M., Mattei, F., Gradilone, A., Alvino, S., Pastore, L. I., Casale, V., Casole, P., Grassi, A., Cianciulli, A. M., and Agliano, A. M. Detection of c-myb genetic alterations and mutant p53 serum protein in patients with benign and malignant colon lesions. Anticancer Res., 14: 1433-1440, 1994.
17. Torelli, G., Venturelli, D., Colo, A., Zanni, C., Selleri, L., Moretti, L., Calabretta, B., and Torelli, U. Expression of c-myb protooncogene and other cell cycle-related genes in normal and neoplastic human colonic mucosa. Cancer Res., 47: 5266-5269, 1987.
18. Guerin, M., Sheng, Z. M., Andrieu, N., and Riou, G. Strong association between c-myb and oestrogen-receptor expression in human breast cancer. Oncogene, 5: 131-135, 1990.
19. Melani, C., Rivoltini, L., Parmiani, G., Calabretta, B., and Colombo, M. P. Inhibition of proliferation by c-myb antisense oligodeoxynucleotides in colon adenocarcinoma cell lines that express c-myb. Cancer Res., 51: 2897-2901, 1991.
20. Barletta, C., Pelicci, P. G., Kenyon, L. C., Smith, S. D., and Dalla Favera, R. Relationship between the c-myb locus and the 6q-chromosomal aberration in leukemias and lymphomas. Science (Washington DC), 235: 1064-1067, 1987.
21. Hall, J. M., Zuppan, P. J., Anderson, L. A., Huey, B., Carter, C., and King, M. C. Oncogenes and human breast cancer. Am. J. Hum. Genet., 44: 577-584, 1989.
22. Yokota, J., Tsunetsugu Yokota, Y., Battifora, H., Le Fevre, C., and Cline, M. J. Alterations of myc, myb, and rasHa proto-oncogenes in cancers are frequent and show clinical correlation. Science (Washington DC), 231: 261-265, 1986.